Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 6/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5611696 | 0.98 | CA2 (0.48) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL3823183 | 0.87 | CA2 (0.59) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL3823186 | 0.87 | CA2 (0.59) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL19435808 | 0.85 | CA2 (0.57) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL19435811 | 0.85 | CA2 (0.57) | CA2MAPK1CA1GRIK1GRIK2 | |
| Oxalic Acid SCHEMBL28551222 | 0.75 | CA2 (0.79) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL23829870 | 0.74 | CA2 (0.86) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL8606737 | 0.74 | CA2 (0.86) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL29946 | 0.74 | CA2 (0.86) | CA2MAPK1CA1GRIK1GRIK2 | |
| SCHEMBL8169390 | 0.74 | CA1 (0.47) | CA2MAPK1CA1SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112754958-B | V73E modified shielding agent, preparation method and application thereof in skin care products | 上海迪摩化学科技有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-112754958-A | V73E modified shielding agent, preparation method and application thereof in skin care products | 上海迪摩化学科技有限公司 | 2021-05-07 | — | — | CN | claimed |
| US-20120321685-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | SOL-GEL TECHNOLOGIES LTD. (IL) | 2012-12-20 | — | — | US | claimed |
| EP-2324812-A2 | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | Sol-Gel Technologies Ltd. (IL) | 2011-05-25 | — | — | EP | claimed |
| EP-1368057-B1 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | TORREY PINES INST (US) | 2009-08-26 | — | — | EP | claimed |
| US-7229621-B2 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2007-06-12 | — | — | US | claimed |
| EP-1071411-B1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2007-03-14 | — | — | EP | claimed |
| EP-1179024-B1 | ORGANOBORANE AMINE COMPLEX INITIATOR SYSTEMS AND POLYMERIZABLE COMPOSITIONS MADE THEREWITH | 3M INNOVATIVE PROPERTIES CO (US) | 2005-03-16 | — | — | EP | claimed |
| US-20050037087-A1 | Compositions containing oils having a specific gravity higher than the specific gravity of water | SOL-GEL TECHNOLOGIES LTD. (IL) | 2005-02-17 | — | — | US | claimed |
| EP-1071411-A4 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INST (US) | 2004-12-08 | — | — | EP | claimed |
| EP-1335693-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS | Sol-Gel Technologies Ltd. (IL) | 2003-08-20 | — | — | EP | claimed |
| WO-2003039510-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | SOL-GEL TECHNOLOGIES LTD. (IL) | 2003-05-15 | — | — | WO | claimed |
| WO-2003034979-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TOPICAL ACTIVE INGREDIENTS | SOL-GEL TECHNOLOGIES LTD. (IL) | 2003-05-01 | — | — | WO | claimed |
| WO-2002074332-A2 | METHOD TO ENHANCE THE IMMUNOGENICITY OF AN ANTIGEN | LANCELL, LLC (US) | 2002-09-26 | — | — | WO | claimed |
| US-20020064541-A1 | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients | SOL-GEL TECHNOLOGIES LTD. (IL) | 2002-05-30 | — | — | US | claimed |
| WO-2001080823-A2 | COMPOSITION EXHIBITING ENHANCED FORMULATION STABILITY AND DELIVERY OF TROPICAL ACTIVE INGREDIENTS | SOL-GEL TECHNOLOGIES LTD. (IL) | 2001-11-01 | — | — | WO | claimed |
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-09-27 | — | — | US | claimed |
| US-6210672-B1 | TOPICAL ADMINISTRATION OF AN ANTIGEN OR A PORTION THEREOF IN CONJUNCTION WITH AN ENHANCER OF SKIN PENETRATION AND AN INDUCER OF LANGERHANS CELL MIGRATION. | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES | 2001-04-03 | — | — | US | claimed |
| EP-1071411-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 2001-01-31 | — | — | EP | claimed |
| WO-1999053912-A1 | TOPICAL IMMUNOSTIMULATION TO INDUCE LANGERHANS CELL MIGRATION | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1999-10-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120321685-A1 | COMPOSITIONS CONTAINING OILS HAVING A SPECIFIC GRAVITY HIGHER THAN THE SPECIFIC GRAVITY OF WATER | GNG2, COG5, SQLE | CA2 3863/4885MAPK1 889/4885CA1 4564/4885 |
| US-20010024649-A1 | Method to enhance the immunogenicity of an antigen | CD69, CD74, LY96 | CA2 2000/4885MAPK1 4495/4885CA1 371/4885 |
| US-20050037087-A1 | Compositions containing oils having a specific gravity higher than the specific gravity of water | GNG2, COG5, SQLE | CA2 3863/4885MAPK1 889/4885CA1 4564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.